FR3023718B1 - PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE - Google Patents

PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE Download PDF

Info

Publication number
FR3023718B1
FR3023718B1 FR1456813A FR1456813A FR3023718B1 FR 3023718 B1 FR3023718 B1 FR 3023718B1 FR 1456813 A FR1456813 A FR 1456813A FR 1456813 A FR1456813 A FR 1456813A FR 3023718 B1 FR3023718 B1 FR 3023718B1
Authority
FR
France
Prior art keywords
decontaminated
pharmaceutical
high pressure
cosmetic compositions
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1456813A
Other languages
French (fr)
Other versions
FR3023718A1 (en
Inventor
Jean Francois Codoliani
Valerie Muguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR1456813A priority Critical patent/FR3023718B1/en
Priority to PCT/EP2015/066328 priority patent/WO2016008999A1/en
Publication of FR3023718A1 publication Critical patent/FR3023718A1/en
Application granted granted Critical
Publication of FR3023718B1 publication Critical patent/FR3023718B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
FR1456813A 2014-07-16 2014-07-16 PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE Active FR3023718B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1456813A FR3023718B1 (en) 2014-07-16 2014-07-16 PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE
PCT/EP2015/066328 WO2016008999A1 (en) 2014-07-16 2015-07-16 Pharmaceutical and/or cosmetic compositions that are decontaminated by high pressure

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1456813 2014-07-16
FR1456813A FR3023718B1 (en) 2014-07-16 2014-07-16 PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE

Publications (2)

Publication Number Publication Date
FR3023718A1 FR3023718A1 (en) 2016-01-22
FR3023718B1 true FR3023718B1 (en) 2018-10-12

Family

ID=51610329

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1456813A Active FR3023718B1 (en) 2014-07-16 2014-07-16 PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE

Country Status (2)

Country Link
FR (1) FR3023718B1 (en)
WO (1) WO2016008999A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3090385B1 (en) 2018-12-21 2021-01-08 Pf Medicament Emollient composition in the form of an emulsion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169121B1 (en) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antivirally active pharmaceutical oil-in-water emulsion containing 9 - [(2-hydroxyethoxy) methyl] guanine (acyclovir) or a salt or ester thereof
EP1380294A1 (en) * 2001-04-17 2004-01-14 Tanabe Seiyaku Co., Ltd. Preventive/remedial agent for inflammatory disease in oral-cavity mucosa and the like
FR2838969B1 (en) * 2002-04-30 2006-05-19 Ellipse Pharmaceuticals METHOD FOR HIGH-PRESSURE STERILIZATION OF PHARMACEUTICAL COMPOSITIONS IN THE MICRO OR NANODISPERSEE FORM AND COMPOSITIONS THUS OBTAINED
US20070293441A1 (en) * 2003-09-22 2007-12-20 Baxter International Inc. High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
RU2392004C2 (en) * 2003-09-22 2010-06-20 Бакстер Интернэшнл Инк. High pressure final sterilisation of pharmaceutic preparations and medical products
WO2006096074A1 (en) * 2005-03-08 2006-09-14 Fonterra Co-Operative Group Limited High pressure processing of bioactive compositions
CN103040849A (en) * 2011-10-12 2013-04-17 新乡医学院 Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof
WO2013114004A1 (en) * 2012-01-31 2013-08-08 Pierre Fabre Dermo-Cosmetique Composition and combination of photostabilising bmdbm sunscreens
FR3010634A1 (en) * 2013-09-13 2015-03-20 Pf Medicament PHARMACEUTICAL COMPOSITIONS BASED ON VEGETABLE SURFACTANTS FOR THE TREATMENT OF HYPOSIALIE

Also Published As

Publication number Publication date
WO2016008999A1 (en) 2016-01-21
FR3023718A1 (en) 2016-01-22

Similar Documents

Publication Publication Date Title
BR112016022062A2 (en) Combination, pharmaceutical composition, use of a combination or pharmaceutical composition, and pharmaceutical product
BR112016015706A2 (en) compound, use of it and pharmaceutical composition
DK3253382T3 (en) PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
DK3089741T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING AZD9291
BR112016026879A2 (en) LIQUID PHARMACEUTICAL COMPOSITION
BR112016018062A2 (en) therapeutic compounds, pharmaceutical composition and uses
MA50541A (en) PHARMACEUTICAL FORMULATIONS
BR112016021034A2 (en) PHARMACEUTICAL COMPOSITION, USE OF SUCH COMPOSITION, METHOD TO TREAT A DISEASE AND KIT
DK3233111T3 (en) PHARMACEUTICAL COMPOSITION COMPRISING PLASMINOGEN AND USES THEREOF
MA42303A (en) PHARMACEUTICAL FORMULATIONS
MA54716A (en) REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS
EP3297640A4 (en) Pharmaceutical co-crystal composition and use thereof
DK3554534T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING INSULIN
MA43705A (en) PHARMACEUTICAL FORMULATION
BR112017013012A2 (en) indenyl compounds, pharmaceutical compositions and medical uses thereof
IL248785B (en) N-[1,5-dimethyl-3-oxo-(2,3-dihydro-1h-pyrazol-4-yl)]-4-methyl-isoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising said derivatives
HK1252534A1 (en) Injectable pharmaceutical formulations of lefamulin
EP3285758A4 (en) Co-crystal composition and its pharmaceutical use
MA42964A (en) ANTI-AGING PHARMACEUTICAL PREPARATION
MA47516A (en) PHARMACEUTICAL COMPOSITION
DK3313370T3 (en) Ophthalmological pharmaceutical composition
DK3236934T3 (en) PHARMACEUTICAL COMPOSITION, PREPARATION AND USES THEREOF
DK3229843T3 (en) PHARMACEUTICAL COMPOSITION, PREPARATION AND APPLICATIONS THEREOF
DK3129057T3 (en) GLYCOLIPIDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THERAPEUTIC USE
BR112016026470A2 (en) Hsp70 modulating compound, pharmaceutical composition comprising it and use of said compound

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160122

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11